Psomagen, Inc. (KOSDAQ: 950200)

Market Cap	85.99B
Revenue (ttm)	34.07B
Net Income (ttm)	-6.15B
Shares Out	19.24M
EPS (ttm)	-333.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,915,124
Open	4,300.00
Previous Close	4,190.00
Day's Range	4,250.00 - 5,250.00
52-Week Range	3,880.00 - 6,700.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Psomagen

Psomagen, Inc. engages in the provision of multi-omics solutions for clinical and research purposes. The company provides genomics, a study of gene sequence and expression; epigenomics, a study of epigenetic changes, such as chromatin assembly, histone modification, and DNA-protein interaction in a cell; metagenomics, a study of genetic material from microorganisms in heterogeneous samples; transcriptomics, a study of RNA and its expression through sequencing, offered to analyze the impact of gene expression on the biology of an organism; and p...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2004
• Employees: 89
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950200